Lecture Notes on Blood Group Incompatibility and Rh Incompatibility
Overview
- Topic: Comparison between blood group incompatibility and Rh incompatibility in the context of hemolytic disease of the newborn.
Blood Group Incompatibility
- Frequency & Severity:
- More common but less severe than Rh incompatibility.
- Conditions:
- Mother: Blood group O.
- Fetus: Blood group A or B.
- First Pregnancy:
- Can be affected; no sensitization required.
- Clinical Signs:
- Hepatosplenomegaly is less common.
- Unconjugated hyperbilirubinemia is less common.
- Jaundice is less common.
- Hemolytic anemia is less common.
- Kernicterus is less common.
- Reticulocytosis is less common.
- Presence of nucleated red blood cells in blood smear is less common.
- Coombs Test:
- Weakly positive direct Coombs test.
- Note on Prevention:
- Incompatibility can prevent Rh sensitization by destroying fetal red blood cells with maternal anti-A IgM agglutinins.
Rh Incompatibility
- Frequency & Severity:
- Less common but more severe than blood group incompatibility.
- Conditions:
- Mother: Rh-negative.
- Fetus: Rh-positive.
- Blood group (A, B, AB, O) does not affect this.
- First Pregnancy:
- Safe; sensitization required from a previous pregnancy or event.
- Clinical Signs:
- Hepatosplenomegaly is more common.
- Unconjugated hyperbilirubinemia is more common.
- Jaundice is more common.
- Hemolytic anemia is more severe.
- Kernicterus is more common.
- Reticulocytosis is more common.
- Presence of nucleated red blood cells in blood smear is more common.
- Coombs Test:
- Both direct and indirect Coombs tests are strongly positive.
- Pathophysiology:
- Entire red blood cells are phagocytized by macrophages, indicating severe anemia.
Important Notes
- Protection Mechanism:
- Incompatibility can act as a protective measure against Rh sensitization when incompatible fetal red blood cells are destroyed by maternal antibodies.
Conclusion
- Key Takeaway:
- Understanding the distinction between blood group incompatibility and Rh incompatibility is crucial in managing and preventing hemolytic disease in newborns.
Reminder: Subscribe for updates on similar content.